GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arctic Bioscience AS (OSL:ABS) » Definitions » Total Debt per Share

Arctic Bioscience AS (OSL:ABS) Total Debt per Share : kr0.07 (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Arctic Bioscience AS Total Debt per Share?

kr0.07 (As of Jun. 2024)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Arctic Bioscience AS's Total Debt Per Share for the quarter that ended in Jun. 2024 was kr0.07.

Arctic Bioscience AS Total Debt per Share Historical Data

The historical data trend for Arctic Bioscience AS's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arctic Bioscience AS Total Debt per Share Chart

Arctic Bioscience AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Debt per Share
Get a 7-Day Free Trial 0.31 0.38 0.05 0.05 0.22

Arctic Bioscience AS Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Total Debt per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - 0.05 0.17 0.22 0.07

Arctic Bioscience AS Total Debt per Share Calculation

Arctic Bioscience AS's Total Debt Per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(2.05+3.53)/25.37
=0.22

Arctic Bioscience AS's Total Debt Per Share for the quarter that ended in Jun. 2024 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(1.77+0.00)/25.37
=0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arctic Bioscience AS Total Debt per Share Related Terms

Thank you for viewing the detailed overview of Arctic Bioscience AS's Total Debt per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Arctic Bioscience AS Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arctic Bioscience AS (OSL:ABS) » Definitions » Total Debt per Share
Comparable Companies
OSL:ABTEC OSL:ONCIN OSL:BGBIO OSL:CRNA OSL:PCIB OSL:EXTX OSL:SOFTX OSL:ZLNA OSL:LYTIX VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270 SMMT
Traded in Other Exchanges
9TD:Germany
Address
Industrivegen 42, Orsta, NOR, 6155
Website
https://www.arctic-bioscience.com
Arctic Bioscience AS is a Norwegian biotechnology company. The company is focused on developing products and solutions based on bioactive marine compounds. The product portfolio includes nutraceuticals and pharmaceuticals. It is currently developing a novel, cost-efficient oral treatment (HRO350) for mild-to-moderate psoriasis. Its nutraceutical products are sold globally to both B2C and B2B under the Romega brand. The company operates in Norway, Europe, Australia and APAC.

Arctic Bioscience AS Headlines

No Headlines